Editas Medicine, Inc. Common Stock vs. Moderna, Inc. Common Stock
EDIT
Editas Medicine, Inc. Common Stock
$2.70 -0.74%
VS MRNAModerna, Inc. Common Stock
$154.04 -2.55%
Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| EDIT | MRNA | |
|---|---|---|
| Market Cap | $414.67 million | $61.50 billion |
| Revenue (TTM) | $47.01 million | $2.23 billion |
| Net Income (TTM) | $-73,949,000 | $-3,151,000,000 |
MRNA leads on 2 of 3 size & scale factors.
Valuation
| EDIT | MRNA | |
|---|---|---|
| Price / Book | 3.94 | 9.10 |
| Price / Sales | 8.82 | 27.60 |
EDIT leads on 2 of 2 valuation factors.
Profitability
| EDIT | MRNA | |
|---|---|---|
| Net Margin | -157.32% | -141.43% |
| Return on Equity | -70.24% | -46.61% |
MRNA leads on 2 of 2 profitability factors.
Risk & Sentiment
| EDIT | MRNA | |
|---|---|---|
| Short Interest | 4.06% | 0.01% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: EDIT overview, EDIT financials, MRNA overview, MRNA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.